Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers
Cells · 18.08.2025 · 14 (16) · 1272
DOI: 10.3390/cells14161272 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 18.08.2025. Verfasst von Sara E Berman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Parkinson's Disease and Movement Disorders Center, Department of Neurology, Pennsylvania Hospital, Perelman School of Medicine, University of Pennsyl…. Hauptthemen laut MEDLINE: alpha-Synuclein, Positron-Emission Tomography, Biomarkers, Synucleinopathies. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH.
Abstract (Originalsprache)
Synucleinopathies are neurodegenerative disorders defined by the pathological aggregation of α-synuclein. Several α-synuclein biomarkers have been developed to aid diagnosis and research, such as cerebrospinal fluid (CSF) and blood-based measurements, seed amplification assays (SAAs), and immunohistochemical detection from skin biopsies. While these existing biomarkers have important uses, they face limitations in diagnostic specificity, spatial localization, and the ability to monitor disease progression or response to therapy. The development of α-synuclein PET tracers, which would allow for the direct in vivo imaging of α-synuclein, represents an important unmet need in both research and the clinical care of patients with movement disorders. This review outlines the current landscape of α-synuclein biomarkers and discusses both the scientific and technical challenges in developing α-synuclein PET imaging tracers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Parkinson's Disease and Movement Disorders Center, Department of Neurology, Pennsylvania Hospital, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Förderung
- NINDS NIH HHS
- NIH
Zitieren
APA
Berman, S. E., & Siderowf, A. D. (2025). Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers. Cells, 14(16), 1272. https://doi.org/10.3390/cells14161272
Vancouver
Berman SE, Siderowf AD. Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers. Cells. 2025;14(16):1272. doi:10.3390/cells14161272
BibTeX
@article{Berman2025,
author = {Berman, Sara E and Siderowf, Andrew D},
title = {Current Status of α-Synuclein Biomarkers and the Need for α-Synuclein PET Tracers},
journal = {Cells},
year = {2025},
volume = {14},
number = {16},
pages = {1272},
doi = {10.3390/cells14161272}
}
EUVIMED